| 1 | Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-ß Production through Its Interaction with A2AR/A2BR | Coautor: Don-López C.A., García-Rocha R., Monroy-García A., Vázquez-Cruz A.L., et al. | 2024 | Pharmaceuticals | WoS-id: 001193440800001
Scopus-id: 2-s2.0-85188992608
| 1 | 2 |
| 2 | Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A2AR/A2BR and the production of TGF-ß1 | Coautor: Don-López C.A., Marín-Aquino L.A., Mora-García M.D.L., Moreno-Lafont M.C., et al. | 2024 | CELL BIOCHEMISTRY AND FUNCTION | WoS-id: 001201745700001
Scopus-id: 2-s2.0-85190280786
| 1 | 2 |
| 3 | Inhibition of CD73 expression or A2AR blockade reduces MRP1 expression and increases the sensitivity of cervical cancer cells to cisplatin | Coautor: Don-Lopez, Christian A., Carrera-Martinez, Monserrat, Mora-Garcia, Maria de L., Garcia-Rocha, Rosario, et al. | 2023 | CELL BIOCHEMISTRY AND FUNCTION | WoS-id: 000939696900001
Scopus-id: 2-s2.0-85149284713
| 6 | 4 |
| 4 | Evidence that cervical cancer cells cultured as tumorspheres maintain high CD73 expression and increase their protumor characteristics through TGF-beta production | Coautor: Azucena Don-Lopez, Christian, Garcia-Rocha, Rosario, Monroy-Garcia, Alberto, Carrera-Martinez, Monserrat, et al. | 2022 | CELL BIOCHEMISTRY AND FUNCTION | WoS-id: 000850603600001
Scopus-id: 2-s2.0-85137512681
| 11 | 9 |
| 5 | Inhibition of adenosine deaminase activity reverses resistance to the cytotoxic effect of high adenosine levels in cervical cancer cells | Coautor: Don-Lopez, Christian Azucena, Monroy-Mora, Alberto, de Lourdes Mora-García M., Alheli Monroy Mora K., et al. | 2022 | Cytokine | WoS-id: 000899099100003
Scopus-id: 2-s2.0-85135392846
| 4 | 3 |
| 6 | Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells | Coautor: Don-López C.A., Torres-Pineda D.B., Mora-García M.D.L., Garcia-Rocha, Rosario, et al. | 2020 | Cytokine | WoS-id: 000527733500001
Scopus-id: 2-s2.0-85082874126
| 9 | 9 |
| 7 | Adenosine augments the production of IL-10 in cervical cancer cells through interaction with the A2B adenosine receptor, resulting in protection against the activity of cytotoxic T cells (vol 130, 155082, 2020) | Coautor: Azucena Don-Lopez, Christian, Berenice Torres-Pineda, Daniela, de Lourdes Mora-Garcia, Maria, Garcia-Rocha, Rosario, et al. | 2020 | Cytokine | WoS-id: 000554002300007
Scopus-id: 2-s2.0-85084458778
| 2 | 2 |
| 8 | Detection of CD39 and a Highly Glycosylated Isoform of Soluble CD73 in the Plasma of Patients with Cervical Cancer: Correlation with Disease Progression | Coautor: Azucena Don-López C., Muñóz-Godínez R., de Lourdes Mora-García M., Weiss-Steider B., et al. | 2020 | MEDIATORS OF INFLAMMATION | WoS-id: 000601168000003
Scopus-id: 2-s2.0-85098092036
| 8 | 6 |
| 9 | Mesenchymal Stromal Cells Derived from Normal Cervix and Cervical Cancer Tumors Increase CD73 Expression in Cervical Cancer Cells Through TGF-ß1 Production | Coautor: López C.A.D., Ávila-Ibarra L.R., Mora-Garcia M.D.L., Garcia-Rocha, Rosario, et al. | 2019 | STEM CELLS AND DEVELOPMENT | WoS-id: 000462935300005
Scopus-id: 2-s2.0-85063814400
| 19 | 21 |
| 10 | HPV-16 Infection Is Associated with a High Content of CD39 and CD73 Ectonucleotidases in Cervical Samples from Patients with CIN-1 | Coautor: Azucena Don-Lopez, Christian, de Lourdes Mora-Garcia, Maria, Lopez-Cisneros, Sofia, Gutierrez-Serrano, Vianey, et al. | 2019 | MEDIATORS OF INFLAMMATION | WoS-id: 000468513600001
Scopus-id: 2-s2.0-85066022685
| 17 | 17 |
| 11 | Cervical cancer cells produce TGF-beta 1 through the CD73-adenosine pathway and maintain CD73 expression through the autocrine activity of TGF-beta 1 | Coautor: Azucena Don-Lopez, Christian, Garcia-Rocha, Rosario, Monroy-Garcia, Alberto, Hernandez-Montes, Jorge, et al. | 2019 | Cytokine | WoS-id: 000475995200010
Scopus-id: 2-s2.0-85054451890
| 26 | 25 |
ID's SCOPUS 
ORCID's 